Cross Research S.A.
Also known as: CROSS Research, Arzo, Ticino, Switzerland | Cross Research SA | Cross Research S.A. | CROSS Research SA | CROSS-Research SA | CROSS Research S.A., I Unit, | CROSS Research S.A., Phase I Clinical Unit, Arzo, Switzerland | Cross Research S.A. Phase I Unit | CROSS Research S.A. Phase I Unit | CROSS Research S.A., Phase I Unit | CROSS Research SA, Phase I Unit, Via FA Giorgioli 12, 6864 Arzo Switzerland | CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 CH-6864 Arzo, Switzerland | Cross S.A.
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2006Last known activity
Apr 13, 2025
Timeline
1990s
- Jun 1, 1996
Cross Research S.A.— Founded
Drugs by trial phase (41 distinct, 42 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (28 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07199543CollaboratorPhase 1Apr 13, 2025
- NCT06705998OfficialPhase 1Dec 15, 2024
- NCT05926258CollaboratorPhase 3Feb 29, 2024
- NCT06840769OfficialPhase 1Jun 17, 2023
- NCT06358586CollaboratorN/AApr 9, 2022
- NCT04932850CollaboratorPhase 1Mar 1, 2021
- NCT04819438Reponsible party - principal investigatorPhase 1Jan 15, 2021
- NCT04819438Overall official - principal investigatorPhase 1Jan 15, 2021
- NCT04819438Lead sponsorPhase 1Jan 15, 2021
- NCT04854642Overall official - principal investigatorPhase 1Oct 20, 2020
- NCT05136521CollaboratorPhase 1Feb 17, 2020
- NCT03821415CollaboratorPhase 2Jan 18, 2019
- NCT04678076Overall official - principal investigatorPhase 1Jul 23, 2018
- NCT04678076CollaboratorPhase 1Jul 23, 2018
- NCT04670601Overall official - principal investigatorPhase 1Jun 19, 2018
Details
- Founded
- Arzo, CH Jun 1, 1996
- Last known activity
- Apr 13, 2025